Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 294 Next >>

Filter Applied: iatrogenic neurologic disorders (Click to remove)

Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012

Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002

Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023

Clinicopathologic Conference, Fat Embolism Syndrome
NEJM 385:2464-2474, Case 39-2021, 2021

Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021

Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016

Growth Hormone Treatment for Childhood Short Stature and Risk of Stroke in Early Adulthood
Neurol 83:780-786, Poidvin, a.,et al, 2014

Thrombolysis for Ischemic Stroke Associated with Infective Endocarditis
Stroke 44:2917-2919, Asaithambi, G.,et al, 2013

Infective Endocarditis at Autopsy
Medicine 91:152-164, Fernandez Guerrero,M.L.,et al, 2012

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Delayed Leukoencephalopathy with Stroke-Like Presentation in Chemotherapy Recipients
JNNP 79:535-539, Baehring,J.M. &Fulbright,R.K., 2008

Clinical and Radiological Characteristics of Methotrexate-Induced Acute Encephalopathy in Pediatric Patients with Cancer
Ann Oncol 19:178-184, Inaba, H.,et al, 2008

Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007

Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis
Mod Rheumatol 17-72-74, Yamamoto, M.,et al, 2007

Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006

Spectrum and Prognosis of Neurologic Complications After Hematopoietic Transplantation
Neurol 67:1990-1997, Denier,C.,et al, 2006

Prevalence of Leukoencephalopathy in Children Treated for Acute Lymphoblastic Leukemia with High-Dose Methotrexate
AJNR 26:1263-1269, Reddick,W.E.,et al, 2005

NOA-03 Trial of High-Dose Methotrexate in Primary Central Nervous System Lymphoma:Final Report
Ann Neurol 57:843-847, Herrlinger,W.,et al, 2005

Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005

Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004

Toxic Leukoencephalopathy
NEJM 345:425-432, Filley,C.M. &Kleinschmidt-DeMasters,B.K., 2001

Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001

Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000

Acute Disseminated Encephalomyelitis After Parenteral Therapy with Herbal Extracts: A Report of Two Cases
JNNP 69:516-518, Schwarz,S.,et al, 2000

Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000

Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

Early Neurologic Complications Following Allogeneic Bone Marrow Transplant for Leukemia, a Prospective Study
Neurol 50:1441-1445, Antonini,G.,et al, 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997

Acute Stroke:Usefulness of Early CT Findings Before Thrombolytic Therapy
Radiology 205:327-333, von Kummer,R.,et al, 1997

Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996

Neur Complic of Autologous & Allogeneic Bone Marrow Transplant in Pts with Leukemia:Comparative Study
Neurol 46:1004-1009, Graus,F.,et al, 1996

Clin Features & Pathog of Intracerebral Hemorrhage after rt-PA & Heparin Therapy for Acute Myocardial Infarct
Neurol 45:649-658, Sloan,M.A.,et al, 1995

Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995

Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995

Hirudin in Acute Myocardial Infarction
Circulation 90:1624-1630, 1631, 2147994., Antman,E.M., 1994

Intracerebral Hemorrhage After Fibrinolytic Therapy for Acute Myocardial Infarction
C. R. , Stroke 24:554-557, 5233., Wijdicks,E.F.M.&Jack,Jr, 1993

Individual Risk Assessment for Intracranial Haemorrhage During Thrombolytic Therapy
Lancet 342:1523-1528, Simoons,M.L.,et al, 1993

Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992

CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991

Complications Associated with Ommaya Reservoirs in Patients with Cancer
Arch Int Med 150:173-176, Lishner,M.,et al, 1990

Adverse Drug Effects Attributed to Phenylpropanolamine:A Review of 142 Case Reports
Am J Med 89:195-208, Lake,C.R.,et al, 1990

Cerebrovascular Complications of L-Asparaginase Therapy
Neurol 38:127-133, Feinberg,W.M.&Swenson,M.R., 1988



Showing articles 0 to 50 of 294 Next >>